Flavonoid naringenin: A potential immunomodulator for Chlamydia trachomatis inflammation

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Yilma, Abebayehu N ^a   Singh, Shree R ^a   Morici, Lisa ^b   Dennis, Vida A ^a  

^a ALABAMA STATE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; CXCL1 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NARINGENIN; RANTES; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; FLAVANONE DERIVATIVE; IMMUNOLOGIC FACTOR; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DEATH; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; CELL LINE; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; DRUG EFFECTS;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FLAVANONES; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878634805     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/102457     Document Type: Article

References (49)

1. Brunham R. C., Rey-Ladino J., Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nature Reviews Immunology 2005 5 2 149 161 2-s2.0-13444301093 10.1038/nri1551 (Pubitemid 40208904)
2. Bavoil P. M., Hsia R. C., Ojcius D. M., Closing in on Chlamydia and its intracellular bag of tricks. Microbiology 2000 146 11 2723 2731 2-s2.0-0033724478
3. Miyairi I., Ramsey K. H., Patton D. L., Duration of untreated Chlamydia genital infection and factors associated with clearance: review of animal studies. The Journal of Infectious Diseases 2010 201 2 S96 S103 2-s2.0-77953111064 10.1086/652393
4. Darville T., Hiltke T. J., Pathogenesis of genital tract disease due to Chlamydia trachomatis. Journal of Infectious Diseases 2010 201 2 S114 S125 2-s2.0-77953102683 10.1086/652397
5. Stephens R. S., The cellular paradigm of Chlamydia pathogenesis. Trends in Microbiology 2003 11 44 51
6. Rasmussen S. J., Eckmann L., Quayle A. J., Shen L., Zhang Y. X., Anderson D. J., Fierer J., Stephens R. S., Kagnoff M. F., Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in Chlamydia pathogenesis. The Journal of Clinical Investigation 1997 99 1 77 87 2-s2.0-0031020373 (Pubitemid 27058297)
7. Yu Y., Zhang Y., Hu S., Different patterns of cytokines and chemokines combined with IFN- γ production reflect Mycobacterium tuberculosis infection and disease. PLoS ONE 2012 7 9 e44944
8. Morrison S. G., Morrison R. P., In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infection and Immunity 2000 68 5 2870 2879 2-s2.0-0034114441 10.1128/IAI.68.5.2870-2879.2000 (Pubitemid 30253867)
9. Yilma A. N., Singh S. R., Fairley S. J., Taha M. A., Dennis V. A., The anti-inflammatory cytokines, interleukin-10 inhibits inflammatory mediators in human epithelial cells and mouse macrophages to live and UV-inactivated Chlamydia trachomatis. Mediators of Inflammation 2012 2012 10 520174 10.1155/2012/520174
10. Ramsey K. H., Sigar I. M., Schripsema J. H., Shaba N., Cohoon K. P., Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice. Infection and Immunity 2005 73 10 6962 6973 2-s2.0-25444508208 10.1128/IAI.73.10.6962-6973.2005 (Pubitemid 41368865)
11. Ault K. A., Kelly K. A., Ruther P. A., Izzo A. A., Izzo L. S., Sigar I. M., Ramsey K. H., Chlamydia trachomatis enhances the expression of matrix metalloproteinases in an in vitro model of the human fallopian tube infection. American Journal of Obstetrics and Gynecology 2002 187 5 1377 1383 2-s2.0-0036855746 10.1067/mob.2002.126850 (Pubitemid 35397489)
12. Romagnolo D. F., Selmin O. I., Flavonoids and cancer prevention: review of the evidence. Journal of Nutrition in Gerontology and Geriatrics 2012 31 3 206 238
13. Bukhari S. N., Jantan I., Jasamai M., Anti-inflammatory trends of 1, 3-Diphenyl-2-propen-1-one derivatives. Mini- Reviews in Medicinal Chemistry 2013 13 87 94
14. Meiyanto E., Hermawan A., Anindyajati, Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pacific Journal of Cancer Prevention 2009 13 2 427 436
15. Bengmark S., Mesa M. D., Gil Hernández A., Plant-derived health: the effects of turmeric and curcuminoids. Nutricion Hospitalaria 2009 24 3 273 281 2-s2.0-68049145089
16. Tripoli E., Guardia M. L., Giammanco S., Majo D. D., Giammanco M., Citrus flavonoids: molecular structure, biological activity and nutritional properties: a review. Food Chemistry 2007 104 2 466 479 2-s2.0-34247468812 10.1016/j.foodchem.2006.11.054 (Pubitemid 46661050)
17. Chao C. L., Weng C. S., Chang N. C., Lin J. S., Kao S. T., Ho F. M., Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia. Nutrition Research 2010 30 12 858 864 2-s2.0-78649938112 10.1016/j.nutres.2010.10.011
18. Tsai S. J., Huang C. S., Mong M. C., Kam W. Y., Huang H. Y., Yin M. C., Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice. Journal of Agricultural and Food Chemistry 2012 60 514 521
19. Iwamura C., Shinoda K., Yoshimura M., Watanabe Y., Obata A., Nakayama T., Naringenin chalcone suppresses allergic asthma by inhibiting the type-2 function of CD4 T cells. Allergology International 2010 59 1 67 73 2-s2.0-77949686197 10.2332/allergolint.09-OA-0118
20. Vafeiadou K., Vauzour D., Lee H. Y., Rodriguez-Mateos A., Williams R. J., Spencer J. P. E., The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Archives of Biochemistry and Biophysics 2009 484 1 100 109 2-s2.0-62349089860 10.1016/j.abb.2009.01.016
21. Du G., Jin L., Han X., Song Z., Zhang H., Liang W., Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis. Cancer Research 2009 69 7 3205 3212 2-s2.0-66149151048 10.1158/0008-5472.CAN-08-3393
22. Bodet C., La V. D., Epifano F., Grenier D., Naringenin has anti-inflammatory properties in macrophage and ex vivo human whole-blood models. Journal of Periodontal Research 2008 43 4 400 407 2-s2.0-45549094966 10.1111/j.1600-0765.2007.01055.x
23. Matsuo M., Sasaki N., Saga K., Kaneko T., Cytotoxicity of flavonoids toward cultured normal human cells. Biological and Pharmaceutical Bulletin 2005 28 2 253 259 2-s2.0-19444369140 10.1248/bpb.28.253 (Pubitemid 40880004)
24. Mahrooz A., Rashidi M. R., Nouri M., Naringenin is an inhibitory of human serum paraoxonase(PON1): an in vitro study. Journal of Clinical Laboratory Analysis 2011 25 395 401
25. Gautam A., Dixit S., Philipp M. T., Interleukin-10 alters effect functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation. Infection and Immunity 2011 79 12 4876 4892
26. Roger T., Casson N., Croxatto A., Entenza J. M., Pusztaszeri M., Akira S., Reymond M. K., Roy D. L., Calandra T., Greub G., Role of MyD88 and toll-like receptors 2 and 4 in the sensing of parachlamydia acanthamoebae. Infection and Immunity 2010 78 12 5195 5201 2-s2.0-78649940866 10.1128/IAI.00786-10
27. Bas S., Neff L., Vuillet M., Spenato U., Seya T., Matsumoto M., Gabay C., The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. Journal of Immunology 2008 180 2 1158 1168 2-s2.0-40449107043
28. O'Connell C. M., AbdelRahman Y. M., Green E., Toll like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromomosal Loci are coordinately in response to glucose limitation by C. trachomatis but not by C. muridarum. Infection and Immunity 2011 79 3 1044 1056
29. + T cells during Pulmonary infection with Chlamydia pneumonia. PLoS ONE 2011 6 11 e26101
30. Hoebe K., Janssen E., Beutler B., The interface between innate and adaptive immunity. Nature Immunology 2004 5 10 971 974 2-s2.0-5444234216 10.1038/ni1004-971 (Pubitemid 41057712)
31. Zarubin T., Han J., Activation and signaling of the p38 MAP kinase pathway. Cell Research 2005 15 1 11 18 2-s2.0-19644367000 10.1038/sj.cr.7290257 (Pubitemid 41653958)
32. Warny M., Keates A. C., Keates S., Castagliuolo I., Zacks J. K., Aboudola S., Qamar A., Pothoulakis C., LaMont J. T., Kelly C. P., p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. The Journal of Clinical Investigation 2000 105 8 1147 1156 2-s2.0-0034049140 (Pubitemid 30217700)
33. Hollenbach E., Neumann M., Vieth M., Roessner A., Malfertheiner P., Naumann M., Inhibition of p38 MAP kinase- and RICK/NF- B-signaling suppresses inflammatory bowel disease. The FASEB Journal 2004 18 13 1550 1552 2-s2.0-9444228220 10.1096/fj.04-1642fje (Pubitemid 39561629)
34. Murthy P. K., Dennis V. A., Lasater B. L., Philipp M. T., Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infection and Immunity 2000 68 12 6663 6669 2-s2.0-0034442793 10.1128/IAI.68.12.6663-6669.2000 (Pubitemid 32463368)
35. Lakshmi V., Joseph S. K., Srivastava S., Verma S. K., Sahoo M. K., Dube V., Mishra S. K., Murthy P. K., Antifilarial activity in vitro and in vivo of some flavonoids tested against Brugia malayi. Acta Tropica 2010 116 2 127 133 2-s2.0-77956474491 10.1016/j.actatropica.2010.06.006
36. Celiz G., Daz M., Audisio M. C., Antibacterial activity of naringenin derivatives. Journal of Applied Microbial 2011 111 3 731 738
37. Kaul T. N., Middleton E. Jr., Ogra P. L., Antiviral effect of flavonoids on human viruses. Journal of Medical Virology 1985 15 1 71 79 2-s2.0-0022006859 (Pubitemid 15184364)
38. Shi Y. S., Dai J. D., Lui H., Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF- B activity in a murine model of asthma. Canadian Journal of Physiology Pharmacology 2009 87 729 735
39. Shaw J. L. V., Wills G. S., Lee K. F., Chlamydia trachomatis infection increase fallopian tube PROKR2 via TLR2 and NF- B activation resulting in a microenvironment predisposed to ectopic pregnancy. The American Journal of Pathology 2010 178 1 253 259
40. Gross J. A., St. John T. T., Allison J. P., The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. The Journal of Immunology 1990 144 8 3201 3210 2-s2.0-0025273486 (Pubitemid 20149501)
41. Lenschow D. J., Walunas T. L., Bluestone J. A., CD28/B7 system of T cell costimulation. Annual Review of Immunology 1996 14 233 258 2-s2.0-0029944533 10.1146/annurev.immunol.14.1.233 (Pubitemid 26130184)
42. Acuto O., Michel F., CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nature Reviews Immunology 2003 3 12 939 951 2-s2.0-0347505003 (Pubitemid 37521536)
43. Lim T. S., Goh J. K. H., Mortellaro A., CD80 and CD86 differentially regulate mechanical interactions of T-Cells with antigen-presenting dendritic Cells and B-Cells. PLoS ONE 2012 7 9 e45185
44. Linsley P. S., Brady W., Urnes M., Grosmaire L. S., Damle N. K., Ledbetter J. A., CTLA-4 is a second receptor for the B cell activation antigen B7. Journal of Experimental Medicine 1991 174 3 561 569 2-s2.0-0025830902
45. Linsley P. S., Greene J. L., Brady W., Bajorath J., Ledbetter J. A., Peach R., Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994 1 9 793 801 2-s2.0-0028675006
46. Buchholz K. R., Stephens R. S., The extracellular signal-regulated kinase/mitogen-activated protein kinase pathway induces the inflammatory factor interleukin-8 following Chlamydia trachomatis infection. Infection and Immunity 2007 75 12 5924 5929 2-s2.0-36749049173 10.1128/IAI.01029-07 (Pubitemid 350207832)
47. Yang J., Li Q., Zhou X. D., Kolosov V. P., Perelman J. M., Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF- B activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells. Molecular and Cellular Biochemistry 2011 351 1-2 29 40 2-s2.0-79953706863 10.1007/s11010-010-0708-y
48. Yadav V. R., Prasad S., Sung B., Aggarwal B. B., The role of chalcones in suppression of NF- B-mediated inflammation and cancer. International Immunopharmacology 2011 11 3 295 309 2-s2.0-79952104482 10.1016/j.intimp.2010. 12.006
49. Derbigny W. A., Kerr M. S., Johnson R. M., Pattern recognition molecules activated by Chlamydia muridarum infection of cloned murine oviduct epithelial cell lines. Journal of Immunology 2005 175 9 6065 6075 2-s2.0-27144471314 (Pubitemid 41508093)